Dr. Badreddin Edris joined SpringWorks Therapeutics in 2018. He has more than 10 years of experience in private and public equity investing, company formation and operations, corporate and business development, and strategic and product planning in the biotechnology industry. Previously, Badreddin was an investment and operating professional on the private equity team at OrbiMed, where he was involved in deal sourcing, evaluation and execution, as well as post-investment strategic and operational support for biotechnology companies across a range of therapeutic areas and stages of development. Badreddin also co-founded and held operating roles at two OrbiMed portfolio companies, Silverback Therapeutics (where he was Chief Business Officer) and Edgewise Therapeutics (where he was Chief Operating Officer and currently serves on the Board of Directors). Before OrbiMed, Badreddin was a management consultant at Bain & Company, where he collaborated with global pharmaceutical and biotechnology companies on a range of strategic and operational projects. Badreddin received his Ph.D. in genetics from Stanford University, where he was an NSF Research Fellow.